| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438333A2 Anti-fusion assay |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438290A1 Cyclohept b!indole derivatives as spla2 inhibitors |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/21/2004 | EP1438064A1 A method for identification and development of therapeutic agents |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438057A2 Pine cone extracts and uses thereof |
| 07/21/2004 | EP1438055A1 D-tagatose as an anti-biofilm agent |
| 07/21/2004 | EP1438054A1 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438042A2 Polymaleimide compounds and their medical use |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 07/21/2004 | EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors |
| 07/21/2004 | EP0643775B1 Quinone derivatives for enhancing cellular bioenergy |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514712A Nial Compositions and methods of administering same |
| 07/21/2004 | CN1513863A Dieneacetal peroxide glycoside kind derivative and its preparation method and its medicinal composition and use |
| 07/21/2004 | CN1513859A Preparation method of sulfuric acid polysaccharide kind substance 911 oligosaccharide fragment and its application |
| 07/21/2004 | CN1513851A Synthesis method of 5-hydroxy methyl furazolidone |
| 07/21/2004 | CN1513554A Animal rabies virus suggarl mucleorrotein divalent DNA vaccine |
| 07/21/2004 | CN1513553A Vero cell fick-borne encephalitis inactivated vaccine |
| 07/21/2004 | CN1513552A Lung tissue endochylema bacteria (Sacheromyces globosus) series vaccine and diagnoses agent and production method |
| 07/21/2004 | CN1513551A Compound biological preparation composition and its preparation method |
| 07/21/2004 | CN1513550A Lozenge containing liver cell growth promoting agent and interferon |
| 07/21/2004 | CN1513549A Polythylene glycol-interferon alpha foreeze dried preparation |
| 07/21/2004 | CN1513548A Recombination human interferon alpha-2b oral adhesive plaster and its making method |
| 07/21/2004 | CN1513542A Chinese medicinal preparation for treating viral myocarditis and its making method |
| 07/21/2004 | CN1513537A Medicine for treating hepatitis B and its preparation method |
| 07/21/2004 | CN1513533A Chinese medicinal composition for treating fuberculosis |
| 07/21/2004 | CN1513530A Chinese medicine for treating ashen nail and its preparation method |
| 07/21/2004 | CN1513529A Pill for clearing heat and dispelling scourge |
| 07/21/2004 | CN1513526A Blood nourishing and toxin resolving medicine for treating AIDS |
| 07/21/2004 | CN1513521A External use medicine for treating AIDS virus |
| 07/21/2004 | CN1513517A Medicine for treating wind warmth and lung heat pathocondition and its preparation method |
| 07/21/2004 | CN1513505A Method for preparing qingkailing granules |
| 07/21/2004 | CN1513501A Jiedufeitai medicine for disintoxication and beneficial to lung |
| 07/21/2004 | CN1513486A Liver-care composition and its prepn. method |
| 07/21/2004 | CN1513473A Combined medicine contg. adourvowy and selenium compound |
| 07/21/2004 | CN1513457A Anti beta-bactamase antibiotic compound prepn. |
| 07/21/2004 | CN1513454A Dispersion tablet of vasilowy hydrochlaride and its prepn. method |
| 07/21/2004 | CN1513445A Sodium bouttuynin small pellet, and its prepn. method |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158304C Antibacteria frog skin peptide derivative |
| 07/21/2004 | CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158261C Antivirals |
| 07/21/2004 | CN1158104C Chinese medicine preparation for treating acute condyloma |
| 07/21/2004 | CN1158101C Process for preparing medicine to treat hepatitis |
| 07/21/2004 | CN1158087C Process for preparing capsule to treat ganopathy |
| 07/21/2004 | CN1158074C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/21/2004 | CN1158069C Antibacterial oil-in-water emulsions |
| 07/20/2004 | US6765105 Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765005 Fab I inhibitors |
| 07/20/2004 | US6764998 6,11-4C-bicyclic 9a-azalide derivatives |
| 07/20/2004 | US6764996 Bactericides for infections |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses |
| 07/20/2004 | US6764684 Avian herpesvirus-based recombinant infectious bursal disease vaccine |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2231194C Pharmaceutical formulation |
| 07/20/2004 | CA2227548C Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/20/2004 | CA2094122C Direct compression method for preparing pills having cephalosporanic acid derivatives |
| 07/20/2004 | CA2079703C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 07/20/2004 | CA2079482C Antiviral compositions and method for their use |
| 07/15/2004 | WO2004058970A1 Adiponectin promoter and use thereof |
| 07/15/2004 | WO2004058788A1 Lipid a analogues having glucose as the right sugar |
| 07/15/2004 | WO2004058768A1 Acid addition salts of pyrrolopyridazine compound |
| 07/15/2004 | WO2004058757A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058756A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058748A1 Crystalline form of (3r,4r)-4-[3-(s)-hydroxy-3-(6-methoxyquinoline-4-yl)propyl]-1-[2-(2-thienylthio) ethyl]piperidine-3-carboxylic acid |
| 07/15/2004 | WO2004058285A1 Method for producing a biologically active substance |
| 07/15/2004 | WO2004058262A1 Benzoquinolizine-2-carboxylic acid-containing compositions |